The Christie NHS Foundation Trust
Manchester, XX
Dr Price is a Clinical Oncologist at The Christie NHS Foundation Trust and a PhD Research Fellow at the University of Manchester (Manchester, UK). In his clinical practice he focuses on the treatment of head and neck cancers with both radiotherapy and proton beam therapy. He is the radiotherapy quality assurance lead for the UK Phase III TORPEdO (intensity-modulated proton beam therapy vs intensity modulated radiotherapy for multi-toxicity reduction in oropharyngeal cancer) and PROTIS (PROton beam Therapy versus Intensity-modulated radiotherapy for Sinonasal cancer) trials. His research focuses on mathematical modelling and functional imaging to predict tumour response and toxicity.
Disclosures:
Monday, September 30, 2024
8:00 AM – 9:00 AM ET
Monday, September 30, 2024
5:15 PM – 5:20 PM ET